Vir Biotechnology (VIR) Prepaid Assets (2018 - 2026)

Vir Biotechnology has disclosed Prepaid Assets across 9 years of filings, most recently posting $44.8 million for Q1 2026.

• Prepaid Assets for Q1 2026 came in at $44.8 million, up 5.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $44.8 million (up 5.58% YoY), and the FY2025 annual result was $45.1 million, down 5.41% from the prior year.
• Prepaid Assets came in at $44.8 million for Q1 2026 at Vir Biotechnology, down from $45.1 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $85.7 million in Q2 2023 to a low of $4.1 million in Q1 2024.
• The 5-year median for Prepaid Assets is $43.6 million (2025), against an average of $43.6 million.
• Across the five-year window, Prepaid Assets sank 77.09% in 2024 and jumped 934.0% in 2025, its largest moves.
• Vir Biotechnology's Prepaid Assets stood at $26.4 million in 2022, then slumped by 71.21% to $7.6 million in 2023, then jumped by 527.96% to $47.7 million in 2024, then decreased by 5.41% to $45.1 million in 2025, then fell by 0.85% to $44.8 million in 2026.
• The last three Prepaid Assets figures came in at $44.8 million (Q1 2026), $45.1 million (Q4 2025), and $37.0 million (Q3 2025), per Business Quant data.